...
首页> 外文期刊>Journal of Lipid Research >15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5[S]
【24h】

15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5[S]

机译:15-脂氧合酶-1生物合成7s,14s-dihdha意味着溶素D5的生物合成中的15-脂氧合酶-2 [S]

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The two oxylipins 7S,14S-dihydroxydocosahexaenoic acid (diHDHA) and 7S,17S-diHDHA [resolvin D5 (RvD5)] have been found in macrophages and infectious inflammatory exudates and are believed to function as specialized pro-resolving mediators (SPMs). Their biosynthesis is thought to proceed through sequential oxidations of DHA by lipoxygenase (LOX) enzymes, specifically, by human 5-LOX (h5-LOX) first to 7(S)-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-DHA (7S-HDHA), followed by human platelet 12-LOX (h12-LOX) to form 7(S),14(S)-dihydroxy-4Z,8E,10Z,12E,16Z,19Z-DHA (7S,14S-diHDHA) or human reticulocyte 15-LOX-1 (h15-LOX-1) to form RvD5. In this work, we determined that oxidation of 7(S)-hydroperoxy-4Z,8E,10Z,13Z,16Z,19Z-DHA to 7S,14S-diHDHA is performed with similar kinetics by either h12-LOX or h15-LOX-1. The oxidation at C14 of DHA by h12-LOX was expected, but the noncanonical reaction of h15-LOX-1 to make over 80% 7S,14S-diHDHA was larger than expected. Results of computer modeling suggested that the alcohol on C7 of 7S-HDHA hydrogen bonds with the backbone carbonyl of Ile399, forcing the hydrogen abstraction from C12 to oxygenate on C14 but not C17. This result raised questions regarding the synthesis of RvD5. Strikingly, we found that h15-LOX-2 oxygenates 7S-HDHA almost exclusively at C17, forming RvD5 with faster kinetics than does h15-LOX-1. The presence of h15-LOX-2 in neutrophils and macrophages suggests that it may have a greater role in biosynthesizing SPMs than previously thought. We also determined that the reactions of h5-LOX with 14(S)-hydroperoxy-4Z,7Z,10Z,12E,16Z,19Z-DHA and 17(S)-hydroperoxy-4Z,7Z,10Z,13Z,15E,19Z-DHA are kinetically slow compared with DHA, suggesting that these reactions may be minor biosynthetic routes in vivo. Additionally, we show that 7S,14S-diHDHA and RvD5 have anti-aggregation properties with platelets at low micromolar potencies, which could directly regulate clot resolution.
机译:在巨噬细胞和传染性炎症渗出物中发现了两个奥氧哌汀7s,14s-二羟基己烯酸(DiHDHA)和7S,17S-DiHDHA [reatvin D5(RVD5)],并被认为用作专门的Pro-Solarating介质(SPM)。他们的生物合成被认为通过脂氧合酶(LOX)酶的DHA的顺序氧化,具体地,通过人5-LOX(H5-LOX)首先至7(S) - 羟基-4Z,8E,10Z,13Z,16Z,19Z -DHA(7S-HDHA),其次是人血小板12-LOX(H12-LOX),形成7(S),14(S)-DIHYDROXY-4Z,8E,10Z,12E,16Z,19Z-DHA(7S, 14S-DiHDHA)或人网状细胞15-LOX-1(H15-LOX-1)形成RVD5。在这项工作中,我们确定,通过H12-LOX或H15-LOX-使用相似的动力学确定7(s)-yloxoxy-4z,8e,10z,13z,16z,19z-dha至7s,14s-dihdha的氧化。 1。预期H12-LOX的DHA的C14的氧化,但H15-LOX-1的非甘露解反应超过80%7S,14S-DiHDHA大于预期。计算机建模的结果表明,7S-HDHA氢键与ILE399的骨干碳基的C7上的醇,迫使C12的氢抽取在C14上但不是C17。这一结果提出了关于RVD5的合成的问题。令人醒目的是,我们发现H15-LOX-2的含氧化合物7S-HDHA几乎完全在C17,形成RVD5,其具有比H15-LOX-1更快的动力学。在中性粒细胞和巨噬细胞中存在H15-LOX-2的存在表明它在生物合成SPM中可能具有比以前认为的更大的作用。我们还确定H5-LOX的反应,其中14(S) - 氢氧基-4Z,7Z,10Z,12E,16Z,19Z-DHA和17(S)-HyDroperoxy-4z,7z,10z,13z,15e,19z与DHA相比,-DHA是缓慢的,这表明这些反应可能是体内轻微的生物合成途径。此外,我们表明,7S,14s-DihDHA和RVD5具有血小板下的血小板的抗聚集性能,可以直接调节凝块分辨率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号